CD8A and breast cancer: Tumor-derived CXCL1 can recruit immunosuppressive myeloid cells that in turn inhibit CD8+ T cell infiltration77 while CXCL8 has been shown to recruit immunosuppressive neutrophils78, promote angiogenesis79 and maintain breast cancer stem cells80.